Correlation Between Annexon and Inozyme Pharma
Can any of the company-specific risk be diversified away by investing in both Annexon and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Annexon and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Annexon and Inozyme Pharma, you can compare the effects of market volatilities on Annexon and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Annexon with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Annexon and Inozyme Pharma.
Diversification Opportunities for Annexon and Inozyme Pharma
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Annexon and Inozyme is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Annexon and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Annexon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Annexon are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Annexon i.e., Annexon and Inozyme Pharma go up and down completely randomly.
Pair Corralation between Annexon and Inozyme Pharma
Given the investment horizon of 90 days Annexon is expected to generate 0.83 times more return on investment than Inozyme Pharma. However, Annexon is 1.2 times less risky than Inozyme Pharma. It trades about -0.43 of its potential returns per unit of risk. Inozyme Pharma is currently generating about -0.53 per unit of risk. If you would invest 732.00 in Annexon on September 1, 2024 and sell it today you would lose (193.00) from holding Annexon or give up 26.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Annexon vs. Inozyme Pharma
Performance |
| Timeline |
| Annexon |
| Inozyme Pharma |
Annexon and Inozyme Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Annexon and Inozyme Pharma
The main advantage of trading using opposite Annexon and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Annexon position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.| Annexon vs. Immix Biopharma | Annexon vs. Cns Pharmaceuticals | Annexon vs. Hepion Pharmaceuticals | Annexon vs. Day One Biopharmaceuticals |
| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |